1,000X Bigger than Crypto? ($25 Gets You In) 
LIVE ON CAMERA: The man who called #1 tech stocks of 2016, 2018, 2019 & 2020 based on return...

Reveals the details of a new tech set to grow:
113X bigger than the Internet...
600X bigger than 5G...
2,000X BIGGER than Bitcoin.

"This is the biggest investing moment in 400 years — and just $25 gets you in."

Brown believes the rollout could be days away...
Watch Jeff’s presentation HERE before it’s too late.
pixel

EX1 Insider Trading (Exopharm)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Exopharm Insider Trading History Chart

This chart shows the insider buying and selling history at Exopharm by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Exopharm Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for EX1 up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Overnight Trade Opportunity Next Week?!
I'm looking at a BIG Overnight Trade opportunity next week...It's so big...

I'm going to give it to you FREE!

In fact, for the week of October 4-8, you can join our FREE Open House!

You can get ALL our Overnight Trade recommendations, plus ALL of our research and real-time recommendations!
Go Here to Join.
pixel

Exopharm Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/1/2021Ian DixonInsiderExercise83,333A$0.54A$44,583.16
9/13/2019Jason WatsonInsiderIssued100,000A$0.37A$37,000.00
8/19/2019Ian DixonInsiderBuy40,000A$0.37A$14,800.00
See Full Table
Insider Selling at Exopharm?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Exopharm and related companies.

SEC Filings (Institutional Ownership Changes) for Exopharm (ASX:EX1)

Exopharm Limited, a biopharmaceutical company, focuses on developing and commercializing human therapeutics using extracellular vesicles (EVs) as medicines in Australia. The company is developing Naïve EVs as regenerative medicines, including Plexaris for wound healing; and Cevaris used in inflammatory, immunomodulatory, and tissue remodeling activities. Its Engineered EVs products comprise Fortrexo CoV, an engineered EV product that reduce the duration and severity of SARS-CoV-2 infection in the early phase of a patient's exposure to COVID-19; and Plexodox, a platelet derived EV loaded with the approved anti-cancer drug doxorubicin as a novel and improved anticancer drug. The company was founded in 2013 and is headquartered in Melbourne, Australia.
Read More on Exopharm

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Exopharm?

Exopharm's top insider shareholders include:
  1. Ian Dixon (Insider)
1,000X Bigger than Crypto? ($25 Gets You In) 
LIVE ON CAMERA: The man who called #1 tech stocks of 2016, 2018, 2019 & 2020 based on return...

Reveals the details of a new tech set to grow:
113X bigger than the Internet...
600X bigger than 5G...
2,000X BIGGER than Bitcoin.

"This is the biggest investing moment in 400 years — and just $25 gets you in."

Brown believes the rollout could be days away...
Watch Jeff’s presentation HERE before it’s too late.
pixel